Startup of the Week: Photon Therapeutics

Startup-of-the-week-photon-therapeutics-scaled
  • The PhotonUVC Vet is a handheld device which provides a rapid, non-contact treatment to help manage corneal infections in animals.
  • Using patented UVC technology, the PhotonUVC Vet deactivates bacteria, fungi, viruses and other infecting organisms by targeting their DNA, while being designed to preserve healthy host tissue.
  •  Developed initially for veterinary ophthalmology, PhotonUVC Vet is designed to be easy to use in practice, offering a fast, drug-free treatment option that tackles antimicrobial resistance by reducing reliance on conventional.

 

Website: https://photon-therapeutics.com/

 

Photon-Therapeutics-Logo

Tell Us About The PhotonUVC Vet

 

The PhotonUVC Vet is a handheld veterinary device that delivers a targeted low-dose UVC light treatment in five seconds to help manage corneal infections without touching the eye.

The device uses patented UVC technology to deactivate bacteria, fungi, viruses and other infecting organisms by targeting their DNA, while being designed to preserve healthy host tissue.

The PhotonUVC Vet is designed to be easy to use in practice, offering a fast, drug-free treatment option that may reduce reliance on topical antimicrobials and improve treatment compliance.

 

Become-Startup-of-the-Week-Banner

Want to be featured as TechRound’s Startup of the Week? Find out more about this weekly feature, and how to get involved, here.

 

What Makes The PhotonUVC Vet Unique?

 

What makes PhotonUVC Vet unique is its ability to deliver a rapid, non-contact, drug-free treatment for corneal infections using targeted UVC light. Unlike conventional therapies, which typically rely on frequent antibiotic eye drops over days or weeks, the PhotonUVC Vet can provide treatment in a controlled exposure lasting only a few seconds. This not only reduces the burden of ongoing medication administration for pet owners but also helps address the challenges of treatment compliance in veterinary patients.

The technology is also distinctive because it works through a physical antimicrobial mechanism rather than a pharmaceutical one. By damaging the DNA of microorganisms, it has the potential to inactivate a broad range of bacteria, fungi, and viruses without relying on antibiotics. This positions PhotonUVC Vet as an innovative tool in the fight against antimicrobial resistance while offering veterinarians a non-invasive treatment option designed specifically for ocular infections. The combination of speed, ease of use, broad-spectrum antimicrobial activity, and a drug-free approach makes it a novel offering within veterinary ophthalmology.

 

Is There A Market For The PhotonUVC Vet?

 

There is currently a strong market for the PhotonUVC Vet in veterinary medicine, particularly in veterinary ophthalmology, where corneal ulcers and infections are common.

There have been no new antimicrobials authorised for veterinary use this century. The current standard of care relies heavily on topical antibiotics and frequent eye drop administration, which can be difficult for pet owners to manage consistently which means there is a market for a faster, clinic-based, non-contact treatments. PhotonUVC Vet fits into this space by offering a rapid, in-clinic, drug-free approach that may also help reduce reliance on antibiotics, which is increasingly important due to antimicrobial resistance concerns.

As a result, the PhotonUVC Vet is positioned as a versatile clinical tool for any veterinary professional involved in diagnosing and treating ocular infections. While the initial focus is on adoption within specialist ophthalmology referral centres and progressive early-adopter practices, the technology is intended to be accessible to a much broader audience, including first-opinion veterinarians who routinely see and manage infected eyes in general practice.

In human healthcare, the opportunity is potentially much larger but still at an early, stage. The same types of corneal infections seen in animals also occur in humans, and there is strong interest in treatments that reduce antibiotic use and improve speed of care. The device is being developed for future human ophthalmology use and the PhotonUVC is currently undergoing human trials, so there is huge potential for widespread use.

 

Where Can We Find The PhotonUVC Vet?

 

You can find out more at www.photon-therapeutics.com.